Candel Therapeutics Inc <CADL.O>: BofA Global Research Raises to Buy From Neutral; Raises Price Objective to $18 From $12
CADL•Related News
Merck's Keytruda Qlex Approved In Japan For Subcutaneous Administration For All Keytruda Indications Approved In Japan
MRK•
Arcmont Asset Management joins Moody’s Nordics briefing panel on European private credit
MCO•
DraftKings CEO Jason Robins to speak at Wells Fargo Consumer Conference
DKNG•
Lazard names Matt Spence head of defense technology and emerging technology coverage
LAZ•
King Resources unit Heavenly Grace sells rare collectibles for US$432,000
KRFG•